$KBIO Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in HUMANIGEN, INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in HUMANIGEN, INC. Get notifications about new insider transactions in HUMANIGEN, INC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 25 2021 | KBIO | HUMANIGEN, INC | Chappell Dale | Chief Scientific Of ... | Sell | S | 17.80 | 725,000 | 12,907,538 | 8,220,079 | 8.9 M to 8.2 M (-8.11 %) |
Jun 25 2021 | KBIO | HUMANIGEN, INC | Chappell Dale | Chief Scientific Of ... | Sell | S | 18.37 | 101,158 | 1,858,768 | 8,945,079 | 9 M to 8.9 M (-1.12 %) |
Jun 25 2021 | KBIO | HUMANIGEN, INC | Chappell Dale | Chief Scientific Of ... | Sell | S | 18.28 | 96,516 | 1,764,776 | 9,046,237 | 9.1 M to 9 M (-1.06 %) |
Jun 25 2021 | KBIO | HUMANIGEN, INC | Chappell Dale | Chief Scientific Of ... | Sell | S | 17.80 | 200,000 | 3,560,700 | 2,243,807 | 2.4 M to 2.2 M (-8.18 %) |
Jun 25 2021 | KBIO | HUMANIGEN, INC | Chappell Dale | Chief Scientific Of ... | Sell | S | 18.37 | 27,906 | 512,770 | 2,443,807 | 2.5 M to 2.4 M (-1.13 %) |
Jun 25 2021 | KBIO | HUMANIGEN, INC | Chappell Dale | Chief Scientific Of ... | Sell | S | 18.28 | 26,625 | 486,833 | 2,471,713 | 2.5 M to 2.5 M (-1.07 %) |
Jun 25 2021 | KBIO | HUMANIGEN, INC | Chappell Dale | Chief Scientific Of ... | Sell | S | 17.80 | 75,000 | 1,335,263 | 972,361 | 1 M to 972.4 K (-7.16 %) |
Jun 25 2021 | KBIO | HUMANIGEN, INC | Chappell Dale | Chief Scientific Of ... | Sell | S | 18.37 | 10,465 | 192,293 | 1,047,361 | 1.1 M to 1 M (-0.99 %) |
Jun 25 2021 | KBIO | HUMANIGEN, INC | Chappell Dale | Chief Scientific Of ... | Sell | S | 18.28 | 9,985 | 182,574 | 1,057,826 | 1.1 M to 1.1 M (-0.94 %) |
Jun 21 2021 | KBIO | HUMANIGEN, INC | Chappell Dale | Chief Scientific Of ... | Sell | S | 18.50 | 291,798 | 5,398,030 | 9,142,753 | 9.4 M to 9.1 M (-3.09 %) |
Jun 21 2021 | KBIO | HUMANIGEN, INC | Chappell Dale | Chief Scientific Of ... | Sell | S | 19.17 | 131,532 | 2,521,876 | 9,434,551 | 9.6 M to 9.4 M (-1.37 %) |
Jun 21 2021 | KBIO | HUMANIGEN, INC | Chappell Dale | Chief Scientific Of ... | Sell | S | 19.40 | 111,325 | 2,160,061 | 9,566,083 | 9.7 M to 9.6 M (-1.15 %) |
Jun 21 2021 | KBIO | HUMANIGEN, INC | Chappell Dale | Chief Scientific Of ... | Sell | S | 18.50 | 80,496 | 1,489,112 | 2,498,338 | 2.6 M to 2.5 M (-3.12 %) |
Jun 21 2021 | KBIO | HUMANIGEN, INC | Chappell Dale | Chief Scientific Of ... | Sell | S | 19.17 | 36,284 | 695,677 | 2,578,834 | 2.6 M to 2.6 M (-1.39 %) |
Jun 21 2021 | KBIO | HUMANIGEN, INC | Chappell Dale | Chief Scientific Of ... | Sell | S | 19.40 | 34,431 | 667,948 | 2,615,118 | 2.6 M to 2.6 M (-1.30 %) |
Jun 21 2021 | KBIO | HUMANIGEN, INC | Chappell Dale | Chief Scientific Of ... | Sell | S | 18.50 | 30,186 | 558,417 | 1,067,811 | 1.1 M to 1.1 M (-2.75 %) |
Jun 21 2021 | KBIO | HUMANIGEN, INC | Chappell Dale | Chief Scientific Of ... | Sell | S | 19.17 | 13,607 | 260,888 | 1,097,997 | 1.1 M to 1.1 M (-1.22 %) |
Jun 21 2021 | KBIO | HUMANIGEN, INC | Chappell Dale | Chief Scientific Of ... | Sell | S | 19.50 | 12,730 | 248,178 | 1,111,604 | 1.1 M to 1.1 M (-1.13 %) |
Apr 22 2021 | KBIO | HUMANIGEN, INC | Kilcoyne Adrian | Chief Medical Offic ... | Option Exercise | A | 14.99 | 155,000 | 2,323,450 | 155,000 | |
Mar 15 2021 | KBIO | HUMANIGEN, INC | Durrant Cameron | Chief Executive Off ... | Option Exercise | A | 16.07 | 652,640 | 10,487,925 | 652,640 | |
Mar 11 2021 | KBIO | HUMANIGEN, INC | NOMIS BAY LTD. | 10% Owner | Sell | J | 15.49 | 37,912 | 587,257 | 5,342,887 | 5.4 M to 5.3 M (-0.70 %) |
Mar 11 2021 | KBIO | HUMANIGEN, INC | NOMIS BAY LTD. | 10% Owner | Sell | S | 16.02 | 119,201 | 1,909,672 | 5,380,799 | 5.5 M to 5.4 M (-2.17 %) |
Mar 11 2021 | KBIO | HUMANIGEN, INC | NOMIS BAY LTD. | 10% Owner | Sell | S | 16.46 | 32,469 | 534,589 | 5,500,000 | 5.5 M to 5.5 M (-0.59 %) |
Mar 11 2021 | KBIO | HUMANIGEN, INC | NOMIS BAY LTD. | 10% Owner | Sell | S | 17.24 | 83,568 | 1,440,495 | 55,632,469 | 55.7 M to 55.6 M (-0.15 %) |
Mar 01 2021 | KBIO | HUMANIGEN, INC | NOMIS BAY LTD. | 10% Owner | Sell | S | 18.65 | 14,100 | 262,951 | 5,616,037 | 5.6 M to 5.6 M (-0.25 %) |
Mar 01 2021 | KBIO | HUMANIGEN, INC | NOMIS BAY LTD. | 10% Owner | Sell | S | 19.18 | 30,003 | 575,437 | 5,630,137 | 5.7 M to 5.6 M (-0.53 %) |
Mar 01 2021 | KBIO | HUMANIGEN, INC | NOMIS BAY LTD. | 10% Owner | Sell | S | 19.17 | 2,402 | 46,045 | 5,660,140 | 5.7 M to 5.7 M (-0.04 %) |
Feb 24 2021 | KBIO | HUMANIGEN, INC | NOMIS BAY LTD. | 10% Owner | Sell | S | 19.55 | 25,906 | 506,333 | 5,662,542 | 5.7 M to 5.7 M (-0.46 %) |
Feb 24 2021 | KBIO | HUMANIGEN, INC | NOMIS BAY LTD. | 10% Owner | Sell | S | 23.21 | 77,314 | 1,794,690 | 5,688,448 | 5.8 M to 5.7 M (-1.34 %) |
Feb 19 2021 | KBIO | HUMANIGEN, INC | NOMIS BAY LTD. | 10% Owner | Sell | S | 23.50 | 37,300 | 876,364 | 5,765,762 | 5.8 M to 5.8 M (-0.64 %) |
Feb 19 2021 | KBIO | HUMANIGEN, INC | NOMIS BAY LTD. | 10% Owner | Sell | S | 21.70 | 42,408 | 920,042 | 5,803,062 | 5.8 M to 5.8 M (-0.73 %) |
Feb 19 2021 | KBIO | HUMANIGEN, INC | NOMIS BAY LTD. | 10% Owner | Sell | S | 19.92 | 9,700 | 193,214 | 5,845,470 | 5.9 M to 5.8 M (-0.17 %) |
Feb 16 2021 | KBIO | HUMANIGEN, INC | NOMIS BAY LTD. | 10% Owner | Sell | S | 19.68 | 16,423 | 323,221 | 5,855,170 | 5.9 M to 5.9 M (-0.28 %) |
Feb 16 2021 | KBIO | HUMANIGEN, INC | NOMIS BAY LTD. | 10% Owner | Sell | S | 21.01 | 550 | 11,555 | 5,871,593 | 5.9 M to 5.9 M (-0.01 %) |
Feb 10 2021 | KBIO | HUMANIGEN, INC | NOMIS BAY LTD. | 10% Owner | Sell | S | 21.39 | 10,875 | 232,605 | 5,872,143 | 5.9 M to 5.9 M (-0.18 %) |
Feb 10 2021 | KBIO | HUMANIGEN, INC | NOMIS BAY LTD. | 10% Owner | Sell | S | 22.32 | 25,666 | 572,942 | 5,883,018 | 5.9 M to 5.9 M (-0.43 %) |
Feb 10 2021 | KBIO | HUMANIGEN, INC | NOMIS BAY LTD. | 10% Owner | Sell | S | 20.70 | 17,732 | 367,035 | 5,908,684 | 5.9 M to 5.9 M (-0.30 %) |
Feb 04 2021 | KBIO | HUMANIGEN, INC | NOMIS BAY LTD. | 10% Owner | Sell | S | 21.88 | 47,862 | 1,047,077 | 5,926,416 | 6 M to 5.9 M (-0.80 %) |
Feb 04 2021 | KBIO | HUMANIGEN, INC | NOMIS BAY LTD. | 10% Owner | Sell | S | 19.23 | 25,000 | 480,825 | 5,974,278 | 6 M to 6 M (-0.42 %) |
Feb 04 2021 | KBIO | HUMANIGEN, INC | NOMIS BAY LTD. | 10% Owner | Sell | S | 20.03 | 722 | 14,461 | 5,999,278 | 6 M to 6 M (-0.01 %) |
Jan 27 2021 | KBIO | HUMANIGEN, INC | NOMIS BAY LTD. | 10% Owner | Sell | J | 18.78 | 70,000 | 1,314,600 | 6,000,000 | 6.1 M to 6 M (-1.15 %) |
Jan 27 2021 | KBIO | HUMANIGEN, INC | NOMIS BAY LTD. | 10% Owner | Sell | S | 19.23 | 23,140 | 445,028 | 6,070,000 | 6.1 M to 6.1 M (-0.38 %) |
Jan 27 2021 | KBIO | HUMANIGEN, INC | NOMIS BAY LTD. | 10% Owner | Sell | S | 20.08 | 71,892 | 1,443,304 | 6,093,140 | 6.2 M to 6.1 M (-1.17 %) |
Jan 21 2021 | KBIO | HUMANIGEN, INC | NOMIS BAY LTD. | 10% Owner | Sell | S | 18.37 | 2,500 | 45,928 | 6,165,032 | 6.2 M to 6.2 M (-0.04 %) |
Jan 21 2021 | KBIO | HUMANIGEN, INC | NOMIS BAY LTD. | 10% Owner | Sell | S | 21.08 | 6,000 | 126,495 | 6,167,532 | 6.2 M to 6.2 M (-0.10 %) |
Jan 19 2021 | KBIO | HUMANIGEN, INC | NOMIS BAY LTD. | 10% Owner | Sell | S | 19.81 | 50,000 | 990,500 | 6,173,532 | 6.2 M to 6.2 M (-0.80 %) |
Jan 19 2021 | KBIO | HUMANIGEN, INC | NOMIS BAY LTD. | 10% Owner | Sell | S | 18.23 | 30,000 | 546,870 | 6,223,532 | 6.3 M to 6.2 M (-0.48 %) |
Jan 19 2021 | KBIO | HUMANIGEN, INC | NOMIS BAY LTD. | 10% Owner | Sell | S | 18.07 | 25,000 | 451,650 | 6,253,532 | 6.3 M to 6.3 M (-0.40 %) |
Jan 13 2021 | KBIO | HUMANIGEN, INC | NOMIS BAY LTD. | 10% Owner | Sell | S | 18.43 | 14,577 | 268,613 | 6,278,532 | 6.3 M to 6.3 M (-0.23 %) |
Jan 13 2021 | KBIO | HUMANIGEN, INC | NOMIS BAY LTD. | 10% Owner | Sell | S | 19.00 | 10,423 | 198,037 | 6,293,109 | 6.3 M to 6.3 M (-0.17 %) |
Dec 31 2020 | KBIO | HUMANIGEN, INC | NOMIS BAY LTD. | 10% Owner | Sell | S | 22.20 | 500 | 11,101 | 6,303,532 | 6.3 M to 6.3 M (-0.01 %) |
Dec 28 2020 | KBIO | HUMANIGEN, INC | NOMIS BAY LTD. | 10% Owner | Sell | S | 22.05 | 8,401 | 185,234 | 6,304,032 | 6.3 M to 6.3 M (-0.13 %) |
Dec 28 2020 | KBIO | HUMANIGEN, INC | NOMIS BAY LTD. | 10% Owner | Sell | S | 21.09 | 45,000 | 948,870 | 6,312,433 | 6.4 M to 6.3 M (-0.71 %) |
Dec 23 2020 | KBIO | HUMANIGEN, INC | NOMIS BAY LTD. | 10% Owner | Sell | S | 50,000.00 | 50,000 | 2,500,000,000 | 6,357,433 | 6.4 M to 6.4 M (-0.78 %) |
Oct 07 2020 | KBIO | HUMANIGEN, INC | Durrant Cameron | Chief Executive Off ... | Option Exercise | A | 12.14 | 82,622 | 1,003,031 | 82,622 | |
Oct 02 2020 | KBIO | HUMANIGEN, INC | Boehm Rainer J. | Grant | A | 10.64 | 1,519 | 16,162 | 84,986 | 83.5 K to 85 K (+1.82 %) | |
Sep 22 2020 | KBIO | HUMANIGEN, INC | Chappell Dale | Chief Scientific Of ... | Option Exercise | A | 9.65 | 133,760 | 1,290,784 | 133,760 | |
Sep 22 2020 | KBIO | HUMANIGEN, INC | Tousley David L. | See Remarks | Option Exercise | A | 9.65 | 62,700 | 605,055 | 62,700 | |
Sep 22 2020 | KBIO | HUMANIGEN, INC | MORRIS TIMOTHY E | COO and CFO | Option Exercise | A | 9.65 | 151,316 | 1,460,199 | 151,316 | |
Sep 22 2020 | KBIO | HUMANIGEN, INC | Jordan Edward P. | Chief Commercial Of ... | Option Exercise | A | 9.65 | 88,200 | 851,130 | 88,200 | |
Aug 12 2020 | KBIO | HUMANIGEN, INC | NOMIS BAY LTD. | 10% Owner | Sell | S | 5.04 | 17,100 | 86,099 | 32,662,170 | 32.7 M to 32.7 M (-0.05 %) |
Jul 21 2020 | KBIO | HUMANIGEN, INC | NOMIS BAY LTD. | 10% Owner | Sell | S | 5.00 | 261,915 | 1,309,575 | 32,689,270 | 33 M to 32.7 M (-0.79 %) |
Jul 21 2020 | KBIO | HUMANIGEN, INC | NOMIS BAY LTD. | 10% Owner | Sell | S | 5.01 | 38,085 | 190,615 | 32,951,185 | 33 M to 33 M (-0.12 %) |
Jul 02 2020 | KBIO | HUMANIGEN, INC | NOMIS BAY LTD. | 10% Owner | Sell | S | 4.91 | 3,000 | 14,739 | 32,989,270 | 33 M to 33 M (-0.01 %) |
Jun 17 2020 | KBIO | HUMANIGEN, INC | NOMIS BAY LTD. | 10% Owner | Sell | S | 5.73 | 35,000 | 200,652 | 32,992,270 | 33 M to 33 M (-0.11 %) |
Jun 17 2020 | KBIO | HUMANIGEN, INC | NOMIS BAY LTD. | 10% Owner | Sell | S | 5.50 | 30,000 | 165,147 | 33,027,270 | 33.1 M to 33 M (-0.09 %) |
Jun 12 2020 | KBIO | HUMANIGEN, INC | NOMIS BAY LTD. | 10% Owner | Sell | S | 3.48 | 5,000 | 17,385 | 33,057,270 | 33.1 M to 33.1 M (-0.02 %) |
Jun 12 2020 | KBIO | HUMANIGEN, INC | NOMIS BAY LTD. | 10% Owner | Sell | S | 3.65 | 35,000 | 127,785 | 33,062,270 | 33.1 M to 33.1 M (-0.11 %) |
Jun 12 2020 | KBIO | HUMANIGEN, INC | NOMIS BAY LTD. | 10% Owner | Sell | S | 3.03 | 106,000 | 320,650 | 33,097,270 | 33.2 M to 33.1 M (-0.32 %) |
Jun 12 2020 | KBIO | HUMANIGEN, INC | NOMIS BAY LTD. | 10% Owner | Sell | S | 2.98 | 101,010 | 301,313 | 33,203,270 | 33.3 M to 33.2 M (-0.30 %) |
Jun 12 2020 | KBIO | HUMANIGEN, INC | NOMIS BAY LTD. | 10% Owner | Sell | S | 2.18 | 263,250 | 574,148 | 33,304,280 | 33.6 M to 33.3 M (-0.78 %) |
Jun 12 2020 | KBIO | HUMANIGEN, INC | NOMIS BAY LTD. | 10% Owner | Sell | S | 2.00 | 6,000 | 12,000 | 33,567,530 | 33.6 M to 33.6 M (-0.02 %) |
May 21 2020 | KBIO | HUMANIGEN, INC | Durrant Cameron | Chief Executive Off ... | Option Exercise | A | 0.86 | 250,000 | 215,000 | 250,000 | |
Apr 07 2020 | KBIO | HUMANIGEN, INC | Chappell Dale | Buy | C | 0.36 | 1,583,333 | 570,000 | 49,636,917 | 48.1 M to 49.6 M (+3.29 %) | |
Jan 29 2020 | KBIO | HUMANIGEN, INC | Durrant Cameron | Chief Executive Off ... | Option Exercise | A | 0.40 | 318,103 | 127,241 | 318,103 | |
Jan 24 2020 | KBIO | HUMANIGEN, INC | Boehm Rainer J. | Grant | A | 0.38 | 43,421 | 16,500 | 403,588 | 360.2 K to 403.6 K (+12.06 %) | |
Jan 24 2020 | KBIO | HUMANIGEN, INC | Buxton Cheryl | Grant | A | 0.38 | 4,576 | 1,739 | 4,576 | 0 to 4.6 K | |
Jan 24 2020 | KBIO | HUMANIGEN, INC | BARLIANT RONALD | Option Exercise | A | 0.38 | 50,000 | 19,000 | 50,000 | ||
Dec 16 2019 | KBIO | HUMANIGEN, INC | Buxton Cheryl | Option Exercise | A | 0.45 | 715,877 | 322,145 | 715,877 | ||
Nov 12 2019 | KBIO | HUMANIGEN, INC | BARLIANT RONALD | Option Exercise | A | 0.70 | 26,470 | 18,529 | 26,470 | ||
Nov 12 2019 | KBIO | HUMANIGEN, INC | Boehm Rainer J. | Grant | A | 0.70 | 23,571 | 16,500 | 360,167 | 336.6 K to 360.2 K (+7.00 %) | |
Jul 31 2019 | KBIO | HUMANIGEN, INC | Boehm Rainer J. | Grant | A | 0.85 | 19,412 | 16,500 | 336,596 | 317.2 K to 336.6 K (+6.12 %) | |
Jul 31 2019 | KBIO | HUMANIGEN, INC | BARLIANT RONALD | Grant | A | 0.85 | 15,882 | 13,500 | 422,504 | 406.6 K to 422.5 K (+3.91 %) | |
Jun 05 2019 | KBIO | HUMANIGEN, INC | Durrant Cameron | Chief Executive Off ... | Grant | A | 1.25 | 8,000 | 10,000 | 557,207 | 549.2 K to 557.2 K (+1.46 %) |
Jun 04 2019 | KBIO | HUMANIGEN, INC | Chappell Dale | 10% Owner | Buy | J | 0.00 | 586,027 | 0 | 48,053,584 | 47.5 M to 48.1 M (+1.23 %) |
Jun 04 2019 | KBIO | HUMANIGEN, INC | Chappell Dale | 10% Owner | Buy | J | 0.00 | 591,248 | 0 | 47,467,557 | 46.9 M to 47.5 M (+1.26 %) |
May 31 2019 | KBIO | HUMANIGEN, INC | BARLIANT RONALD | Buy | J | 0.00 | 236,499 | 0 | 406,622 | 170.1 K to 406.6 K (+139.02 %) | |
May 31 2019 | KBIO | HUMANIGEN, INC | Durrant Cameron | Chief Executive Off ... | Buy | J | 0.00 | 235,624 | 0 | 549,207 | 313.6 K to 549.2 K (+75.14 %) |
May 30 2019 | KBIO | HUMANIGEN, INC | Boehm Rainer J. | Option Exercise | M | 0.67 | 238,625 | 158,686 | 477,252 | ||
May 30 2019 | KBIO | HUMANIGEN, INC | Boehm Rainer J. | Grant | A | 0.67 | 238,625 | 158,686 | 317,184 | 78.6 K to 317.2 K (+303.75 %) | |
May 16 2019 | KBIO | HUMANIGEN, INC | Savage Robert G. | Option Exercise | M | 0.67 | 100,000 | 66,500 | 615,877 | ||
May 16 2019 | KBIO | HUMANIGEN, INC | Savage Robert G. | Grant | A | 0.67 | 100,000 | 66,500 | 199,869 | 99.9 K to 199.9 K (+100.13 %) | |
Apr 25 2019 | KBIO | HUMANIGEN, INC | Durrant Cameron | Chief Executive Off ... | Option Exercise | M | 0.67 | 75,000 | 49,875 | 8,359,771 | |
Apr 25 2019 | KBIO | HUMANIGEN, INC | Durrant Cameron | Chief Executive Off ... | Grant | A | 0.67 | 75,000 | 49,875 | 313,583 | 238.6 K to 313.6 K (+31.44 %) |
Apr 02 2019 | KBIO | HUMANIGEN, INC | Savage Robert G. | Grant | A | 1.35 | 13,704 | 18,500 | 99,869 | 86.2 K to 99.9 K (+15.90 %) | |
Apr 02 2019 | KBIO | HUMANIGEN, INC | Boehm Rainer J. | Grant | A | 1.35 | 12,222 | 16,500 | 78,559 | 66.3 K to 78.6 K (+18.42 %) | |
Mar 11 2019 | KBIO | HUMANIGEN, INC | Durrant Cameron | Chief Executive Off ... | Option Exercise | M | 0.67 | 75,000 | 49,875 | 8,434,771 | |
Mar 11 2019 | KBIO | HUMANIGEN, INC | Durrant Cameron | Chief Executive Off ... | Grant | A | 0.67 | 75,000 | 49,875 | 238,583 | 163.6 K to 238.6 K (+45.85 %) |
Mar 11 2019 | KBIO | HUMANIGEN, INC | Durrant Cameron | Chief Executive Off ... | Option Exercise | M | 0.67 | 75,000 | 49,875 | 8,434,771 | |
Mar 11 2019 | KBIO | HUMANIGEN, INC | Durrant Cameron | Chief Executive Off ... | Grant | A | 0.67 | 75,000 | 49,875 | 238,583 | 163.6 K to 238.6 K (+45.85 %) |
Jan 28 2019 | KBIO | HUMANIGEN, INC | Jester J Gregory | Chief Financial Off ... | Option Exercise | A | 0.84 | 86,111 | 72,333 | 86,111 | |
Jan 28 2019 | KBIO | HUMANIGEN, INC | Durrant Cameron | Chief Executive Off ... | Option Exercise | A | 0.84 | 142,857 | 120,000 | 142,857 | |
Jan 28 2019 | KBIO | HUMANIGEN, INC | Jester J Gregory | Chief Financial Off ... | Option Exercise | A | 0.84 | 86,111 | 72,333 | 86,111 | |
Jan 28 2019 | KBIO | HUMANIGEN, INC | Durrant Cameron | Chief Executive Off ... | Option Exercise | A | 0.84 | 142,857 | 120,000 | 142,857 | |
Jan 07 2019 | KBIO | HUMANIGEN, INC | Savage Robert G. | Grant | A | 0.74 | 20,946 | 15,500 | 86,165 | 65.2 K to 86.2 K (+32.12 %) | |
Jan 07 2019 | KBIO | HUMANIGEN, INC | Boehm Rainer J. | Grant | A | 0.74 | 18,243 | 13,500 | 66,337 | 48.1 K to 66.3 K (+37.93 %) | |
Jan 07 2019 | KBIO | HUMANIGEN, INC | BARLIANT RONALD | Grant | A | 0.74 | 18,243 | 13,500 | 160,123 | 141.9 K to 160.1 K (+12.86 %) | |
Dec 14 2018 | KBIO | HUMANIGEN, INC | Durrant Cameron | Chief Executive Off ... | Grant | A | 0.82 | 4,000 | 3,264 | 163,583 | 159.6 K to 163.6 K (+2.51 %) |
Dec 14 2018 | KBIO | HUMANIGEN, INC | Durrant Cameron | Chief Executive Off ... | Grant | A | 0.82 | 2,000 | 1,644 | 159,583 | 157.6 K to 159.6 K (+1.27 %) |
Dec 12 2018 | KBIO | HUMANIGEN, INC | Durrant Cameron | Chief Executive Off ... | Grant | A | 0.76 | 2,500 | 1,893 | 157,583 | 155.1 K to 157.6 K (+1.61 %) |
Dec 12 2018 | KBIO | HUMANIGEN, INC | Durrant Cameron | Chief Executive Off ... | Grant | A | 0.75 | 2,500 | 1,875 | 155,083 | 152.6 K to 155.1 K (+1.64 %) |
Dec 10 2018 | KBIO | HUMANIGEN, INC | Durrant Cameron | Chief Executive Off ... | Grant | A | 0.74 | 7,000 | 5,173 | 152,583 | 145.6 K to 152.6 K (+4.81 %) |
Dec 10 2018 | KBIO | HUMANIGEN, INC | Durrant Cameron | Chief Executive Off ... | Grant | A | 0.73 | 10,000 | 7,320 | 145,583 | 135.6 K to 145.6 K (+7.38 %) |
Oct 02 2018 | KBIO | HUMANIGEN, INC | Boehm Rainer J. | Grant | A | 0.64 | 21,094 | 13,500 | 48,094 | 27 K to 48.1 K (+78.13 %) | |
Oct 02 2018 | KBIO | HUMANIGEN, INC | BARLIANT RONALD | Grant | A | 0.64 | 21,094 | 13,500 | 141,880 | 120.8 K to 141.9 K (+17.46 %) | |
Oct 02 2018 | KBIO | HUMANIGEN, INC | Savage Robert G. | Grant | A | 0.64 | 24,219 | 15,500 | 65,219 | 41 K to 65.2 K (+59.07 %) | |
Aug 09 2018 | KBIO | HUMANIGEN, INC | Boehm Rainer J. | Grant | A | 0.50 | 27,000 | 13,500 | 27,000 | 0 to 27 K | |
Aug 09 2018 | KBIO | HUMANIGEN, INC | Savage Robert G. | Grant | A | 0.50 | 31,000 | 15,500 | 41,000 | 10 K to 41 K (+310.00 %) | |
Aug 09 2018 | KBIO | HUMANIGEN, INC | BARLIANT RONALD | Grant | A | 0.50 | 27,000 | 13,500 | 120,786 | 93.8 K to 120.8 K (+28.79 %) | |
Mar 13 2018 | KBIO | HUMANIGEN, INC | MORRIS TIMOTHY E | Option Exercise | A | 0.67 | 88,235 | 58,676 | 88,235 | ||
Mar 13 2018 | KBIO | HUMANIGEN, INC | MORRIS TIMOTHY E | Option Exercise | A | 0.67 | 715,877 | 476,058 | 715,877 | ||
Mar 13 2018 | KBIO | HUMANIGEN, INC | Savage Robert G. | Option Exercise | A | 0.67 | 715,877 | 476,058 | 715,877 | ||
Mar 13 2018 | KBIO | HUMANIGEN, INC | Durrant Cameron | Chief Executive Off ... | Option Exercise | A | 0.67 | 7,466,749 | 4,965,388 | 8,509,771 | |
Mar 13 2018 | KBIO | HUMANIGEN, INC | BARLIANT RONALD | Option Exercise | A | 0.67 | 156,863 | 104,314 | 156,863 | ||
Mar 13 2018 | KBIO | HUMANIGEN, INC | BARLIANT RONALD | Option Exercise | A | 0.67 | 715,877 | 476,058 | 715,877 | ||
Mar 13 2018 | KBIO | HUMANIGEN, INC | Jester J Gregory | Chief Financial Off ... | Option Exercise | A | 0.67 | 284,313 | 189,068 | 284,313 | |
Mar 13 2018 | KBIO | HUMANIGEN, INC | Jester J Gregory | Chief Financial Off ... | Option Exercise | A | 0.67 | 1,073,815 | 714,087 | 1,223,815 | |
Mar 13 2018 | KBIO | HUMANIGEN, INC | Boehm Rainer J. | Option Exercise | A | 0.67 | 715,877 | 476,058 | 715,877 | ||
Mar 07 2018 | KBIO | HUMANIGEN, INC | Jester J Gregory | Chief Financial Off ... | Option Exercise | A | 0.33 | 150,000 | 49,500 | 150,000 | |
Mar 05 2018 | KBIO | HUMANIGEN, INC | NOMIS BAY LTD. | 10% Owner | Buy | P | 0.28 | 29,893,424 | 8,370,159 | 33,573,530 | 3.7 M to 33.6 M (+812.30 %) |
Mar 01 2018 | KBIO | HUMANIGEN, INC | Chappell Dale | 10% Owner | Buy | P | 0.09 | 32,028,669 | 3,001,086 | 46,876,309 | 14.8 M to 46.9 M (+215.72 %) |
Mar 01 2018 | KBIO | HUMANIGEN, INC | Chappell Dale | 10% Owner | Buy | J | 0.00 | 12,812,322 | 0 | 14,847,640 | 2 M to 14.8 M (+629.50 %) |
Mar 01 2018 | KBIO | HUMANIGEN, INC | Chappell Dale | 10% Owner | Buy | J | 0.00 | 11,957,369 | 0 | 13,997,832 | 2 M to 14 M (+586.01 %) |
Mar 01 2018 | KBIO | HUMANIGEN, INC | Chappell Dale | 10% Owner | Buy | J | 0.00 | 5,123,733 | 0 | 5,996,710 | 873 K to 6 M (+586.93 %) |
Mar 01 2018 | KBIO | HUMANIGEN, INC | Chappell Dale | 10% Owner | Buy | P | 0.09 | 32,028,669 | 3,001,086 | 46,876,309 | 14.8 M to 46.9 M (+215.72 %) |
Mar 01 2018 | KBIO | HUMANIGEN, INC | Chappell Dale | 10% Owner | Buy | J | 0.00 | 12,812,322 | 0 | 14,847,640 | 2 M to 14.8 M (+629.50 %) |
Mar 01 2018 | KBIO | HUMANIGEN, INC | Chappell Dale | 10% Owner | Buy | J | 0.00 | 11,957,369 | 0 | 13,997,832 | 2 M to 14 M (+586.01 %) |
Mar 01 2018 | KBIO | HUMANIGEN, INC | Chappell Dale | 10% Owner | Buy | J | 0.00 | 5,123,733 | 0 | 5,996,710 | 873 K to 6 M (+586.93 %) |
Sep 05 2017 | KBIO | HUMANIGEN, INC | NOMIS BAY LTD. | 10% Owner | Sell | S | 0.46 | 38,900 | 17,894 | 3,680,106 | 3.7 M to 3.7 M (-1.05 %) |
Feb 22 2017 | KBIO | KALOBIOS PHARMACEU ... | Tousley David L. | Interim CFO | Option Exercise | A | 2.92 | 100,000 | 292,000 | 100,000 | |
Feb 22 2017 | KBIO | KALOBIOS PHARMACEU ... | Lam Morgan | Chief Scientific Of ... | Option Exercise | A | 2.92 | 100,000 | 292,000 | 100,000 | |
Sep 15 2016 | KBIO | KALOBIOS PHARMACEU ... | MORRIS TIMOTHY E | Director | Option Exercise | A | 3.38 | 100,000 | 338,000 | 100,000 | |
Sep 15 2016 | KBIO | KALOBIOS PHARMACEU ... | BARLIANT RONALD | Director | Option Exercise | A | 3.38 | 100,000 | 338,000 | 100,000 | |
Sep 15 2016 | KBIO | KALOBIOS PHARMACEU ... | Durrant Cameron | Chief Executive Off ... | Option Exercise | A | 3.38 | 1,043,022 | 3,525,414 | 1,043,022 | |
Sep 15 2016 | KBIO | KALOBIOS PHARMACEU ... | Friedberg Ezra M | Director | Option Exercise | A | 3.38 | 100,000 | 338,000 | 100,000 | |
Sep 15 2016 | KBIO | KALOBIOS PHARMACEU ... | Lam Morgan | Chief Scientific Of ... | Option Exercise | A | 3.38 | 100,000 | 338,000 | 100,000 | |
Sep 15 2016 | KBIO | KALOBIOS PHARMACEU ... | Chappell Dale | Director | Option Exercise | A | 3.38 | 100,000 | 338,000 | 100,000 | |
Aug 29 2016 | KBIO | KALOBIOS PHARMACEU ... | Shkreli Martin | 10% Owner | Sell | S | 3.10 | 309,723 | 960,141 | 0 | 309.7 K to 0 (-100.00 %) |
Aug 29 2016 | KBIO | KALOBIOS PHARMACEU ... | Shkreli Martin | 10% Owner | Sell | S | 3.10 | 1,913,206 | 5,930,939 | 309,723 | 2.2 M to 309.7 K (-86.07 %) |
Jul 05 2016 | KBIO | KALOBIOS PHARMACEU ... | Durrant Cameron | Chairman and CEO | Grant | A | 0.00 | 135,583 | 0 | 135,583 | 0 to 135.6 K |